How This Warning from Dr. Fauci May Equal Higher Revenue for Moderna
Moderna (NASDAQ: MRNA) is once again giving its investors reason to cheer. Shares of the coronavirus vaccine maker have increased more than 30% over the past five days, rising as high as $313. As a result, the company crossed into $100 billion market cap territory.
Investors may be anticipating more revenue down the road for the biotech company. That's because the health crisis is deepening once again. The highly contagious delta variant is gaining ground in the U.S. and has become the dominant strain in the country, according to the Centers for Disease Control and Prevention. And health authorities recently said 97% of hospitalized patients these days haven't been vaccinated. Against this backdrop, White House Medical Advisor Dr. Anthony Fauci made a statement that could result in more revenue for Moderna.
Image source: Getty Images.
Source Fool.com
